FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4229333602> ?p ?o ?g. }

• W4229333602 endingPage "1088" @default.
• W4229333602 startingPage "1088" @default.
• W4229333602 abstract "Radiation therapy is an important component of cancer treatment scheduled for cancer patients, although it can cause numerous deleterious effects. The use of adjuvant molecules aims to limit the damage in normal surrounding tissues and enhance the effects of radiation therapy, either killing tumor cells or slowing down their growth. Melatonin, an indoleamine released by the pineal gland, behaves as a radiosensitizer in breast cancer, since it enhances the therapeutic effects of ionizing radiation and mitigates side effects on normal cells. However, the molecular mechanisms through which melatonin modulates the molecular changes triggered by radiotherapy remain mostly unknown. Here, we report that melatonin potentiated the anti-proliferative effect of radiation in MCF-7 cells. Treatment with ionizing radiation induced changes in the expression of many genes. Out of a total of 25 genes altered by radiation, melatonin potentiated changes in 13 of them, whereas the effect was reverted in another 10 cases. Among them, melatonin elevated the levels of PTEN and NME1, and decreased the levels of SNAI2, ERBB2, AKT, SERPINE1, SFN, PLAU, ATM and N3RC1. We also analyzed the expression of several microRNAs and found that melatonin enhanced the effect of radiation on the levels of miR-20a, miR-19a, miR-93, miR-20b and miR-29a. Rather surprisingly, radiation induced miR-17, miR-141 and miR-15a but melatonin treatment prior to radiation counteracted this stimulatory effect. Radiation alone enhanced the expression of the cancer suppressor miR-34a, and melatonin strongly stimulated this effect. Melatonin further enhanced the radiation-mediated inhibition of Akt. Finally, in an in vivo assay, melatonin restrained new vascularization in combination with ionizing radiation. Our results confirm that melatonin blocks many of the undesirable effects of ionizing radiation in MCF-7 cells and enhances changes that lead to optimized treatment results. This article highlights the effectiveness of melatonin as both a radiosensitizer and a radioprotector in breast cancer. Melatonin is an effective adjuvant molecule to radiotherapy, promoting anti-cancer therapeutic effects in cancer treatment. Melatonin modulates molecular pathways altered by radiation, and its use in clinic might lead to improved therapeutic outcomes by enhancing the sensitivity of cancerous cells to radiation and, in general, reversing their resistance toward currently applied therapeutic modalities." @default.
• W4229333602 created "2022-05-09" @default.
• W4229333602 creator A5010161902 @default.
• W4229333602 creator A5011956486 @default.
• W4229333602 creator A5034705690 @default.
• W4229333602 creator A5058643379 @default.
• W4229333602 creator A5063026216 @default.
• W4229333602 creator A5073598943 @default.
• W4229333602 creator A5079686516 @default.
• W4229333602 creator A5081137381 @default.
• W4229333602 date "2022-05-07" @default.
• W4229333602 modified "2023-10-18" @default.
• W4229333602 title "Melatonin Modulation of Radiation-Induced Molecular Changes in MCF-7 Human Breast Cancer Cells" @default.
• W4229333602 cites W1610645793 @default.
• W4229333602 cites W1846326266 @default.
• W4229333602 cites W1987809679 @default.
• W4229333602 cites W1988443105 @default.
• W4229333602 cites W2012896466 @default.
• W4229333602 cites W2015869781 @default.
• W4229333602 cites W2030788602 @default.
• W4229333602 cites W2038409460 @default.
• W4229333602 cites W2061432651 @default.
• W4229333602 cites W2063335267 @default.
• W4229333602 cites W2065258318 @default.
• W4229333602 cites W2066172269 @default.
• W4229333602 cites W2072437379 @default.
• W4229333602 cites W2086331407 @default.
• W4229333602 cites W2086546153 @default.
• W4229333602 cites W2108550510 @default.
• W4229333602 cites W2123879605 @default.
• W4229333602 cites W2125106680 @default.
• W4229333602 cites W2128776855 @default.
• W4229333602 cites W2135731415 @default.
• W4229333602 cites W2160126892 @default.
• W4229333602 cites W2161616089 @default.
• W4229333602 cites W2166307268 @default.
• W4229333602 cites W2167251815 @default.
• W4229333602 cites W2170124346 @default.
• W4229333602 cites W2172123394 @default.
• W4229333602 cites W2342032997 @default.
• W4229333602 cites W2347035654 @default.
• W4229333602 cites W2586055247 @default.
• W4229333602 cites W2587840780 @default.
• W4229333602 cites W2606778500 @default.
• W4229333602 cites W2749000912 @default.
• W4229333602 cites W2781664750 @default.
• W4229333602 cites W2793961297 @default.
• W4229333602 cites W2796350114 @default.
• W4229333602 cites W2885698289 @default.
• W4229333602 cites W2885822300 @default.
• W4229333602 cites W2895447854 @default.
• W4229333602 cites W2903957576 @default.
• W4229333602 cites W2915703688 @default.
• W4229333602 cites W2917793200 @default.
• W4229333602 cites W2921097669 @default.
• W4229333602 cites W2947916475 @default.
• W4229333602 cites W2957121754 @default.
• W4229333602 cites W2960418263 @default.
• W4229333602 cites W2962759822 @default.
• W4229333602 cites W2967577528 @default.
• W4229333602 cites W2975497057 @default.
• W4229333602 cites W3002283538 @default.
• W4229333602 cites W3009186920 @default.
• W4229333602 cites W3012269368 @default.
• W4229333602 cites W3013856967 @default.
• W4229333602 cites W3019164941 @default.
• W4229333602 cites W3038416231 @default.
• W4229333602 cites W3043942157 @default.
• W4229333602 cites W3095726546 @default.
• W4229333602 cites W3098245473 @default.
• W4229333602 cites W3099567292 @default.
• W4229333602 cites W3122933696 @default.
• W4229333602 cites W3124401574 @default.
• W4229333602 cites W3135204771 @default.
• W4229333602 cites W3138347172 @default.
• W4229333602 cites W3139340122 @default.
• W4229333602 cites W3143266409 @default.
• W4229333602 cites W3157579748 @default.
• W4229333602 cites W3169496688 @default.
• W4229333602 cites W3174496988 @default.
• W4229333602 cites W3178923205 @default.
• W4229333602 cites W3181971507 @default.
• W4229333602 cites W3185637828 @default.
• W4229333602 cites W3186797847 @default.
• W4229333602 cites W3197685878 @default.
• W4229333602 cites W3203726643 @default.
• W4229333602 cites W3210199933 @default.
• W4229333602 cites W3210925865 @default.
• W4229333602 cites W4200039125 @default.
• W4229333602 cites W4200412519 @default.
• W4229333602 cites W4220943075 @default.
• W4229333602 cites W4243126678 @default.
• W4229333602 doi "https://doi.org/10.3390/biomedicines10051088" @default.
• W4229333602 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35625825" @default.
• W4229333602 hasPublicationYear "2022" @default.
• W4229333602 type Work @default.
• W4229333602 citedByCount "2" @default.
• W4229333602 countsByYear W42293336022022 @default.

• next